CompletedNot applicableNCT02766673

Aerosolized Albuterol Use in Severe BPD

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Philadelphia
Principal Investigator
Kevin Dysart, MD, MD
Children's Hospital of Philadelphia
Intervention
Albuterol Sulfate(drug)
Enrollment
24 enrolled
Eligibility
1 years · All sexes
Timeline
20162018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02766673 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials